Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
Qi Wang(Jiangsu University), Dmitri Pchejetski(University of East Anglia), Shyam Srivats, Colin Cooper(Institute of Cancer Research), Heba Alshaker(University of East Anglia), Torsten Böhler(Charité - Universitätsmedizin Berlin), Yimin Chao(University of East Anglia)
Cited by 82
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|Cancer Cell|2022|403
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174